ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

37
Analysis
Health CareIndia
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
Refresh
02 Aug 2023 18:16

Concord Biotech (Pre-IPO): Niche Offering Amid Lean Competition to Drive Stable Growth

The IPO consists of offer for sale of 21M shares by Helix Investment Holdings at a price band of INR705–741/share. Through this IPO, Concord seeks...

Logo
281 Views
Share
bullishLaurus Labs
08 Dec 2020 05:54

India: AMFI Stock Categorization Changes to Drive Active Portfolio Churn

The reclassification of stocks to large, mid and small cap will set off a churn in mutual fund portfolios where historically stocks migrating...

Logo
306 Views
Share
bullishAarti Drugs Ltd
12 Sep 2020 14:27

India Small Caps: Position for Outperformance Vs Large & Mid Caps

Late Friday evening, the Securities and Exchange Board of Indian 

Logo
562 Views
Share
bullishLaurus Labs
16 Nov 2018 20:30

Laurus Labs 2QFY19 Results Update - Growth Likely to Begin from FY20E

Laurus Labs (LAURUS IN) disappointed on sales and reported PAT but EBITDA margins (adjusted for one-time costs) were better than our...

Logo
441 Views
Share
bullishLaurus Labs
11 Aug 2018 20:21

Laurus Labs - 1QFY19- One More Difficult Quarter Ahead, Strong Growth in FY20E

Laurus Labs reported 1QFY19 results on 3rd August 2018 and held a conference call on 4th August 2018. Revenues grew 9.7% YoY to Rs. 5,390 Mn,...

Logo
329 Views
Share
x